European stock and US equity futures climb vaccine expectation and M&A action


Capped vials of the COVID-19 vaccine candidate from the University of Oxford, which resumed testing after a pause last week.

Vincenzo Pinto / Agence France-Presse / Getty Images

European shares rose on Monday, with US equity futures driven by news of the vaccine’s expectation, mergers and acquisitions.

Stoxx Europe 600 Index SXXP,
-0.02%
Increased 0.3% after ending the previous week almost 1.7% higher, 7. The best weekly return since the week ending August. German Dax Dax,
-0.08%
0.3% achieved, French CAC 40 PX1,
+ 0.15%
Rose 0.4%, while the FTSE 100 Index UKX,
-0.15%
The flat was trading.

Investors will hear from the Federal Reserve, the Bank of England and the Bank of Japan in the coming days on a busy week for central bank meetings.

Wall Street was also pointing to a strong start with the Nasdaq-100 futures NQ00,
+ 1.12%
145 points or 1.3% increase, while the S&P 500 futures ES00,
+ 0.96%
38.95 points or 1.2%, and the Dow Jones Industrial Average futures made YM00 cry
+ 0.77%
Jumped 278 points, or 1%.

Those gains came at a week’s height for Wall Street with the Dow DJIA,
+ 0.47%
Dropping 1.7%, S&P 500 SPX,
0.05%
2.5% decline and Nasdaq comp,
-0.60%
Its 4.1% drop, its worst weekly loss since the week ending March 20.

Renewed hopes on the coronovirus vaccine also helped improve at the beginning of the week.

PFE of Pfizer Inc.
+ 1.17%
Chief Executive Officer Albert Borla said in an interview on Sunday that the drugmaker should know if its COVID-19 vaccine candidate will work until the end of October – and if approved, distribute it to the US by the end of the year can go. Pfizer is partnering with German drugmaker BioNotech BNTT.
+ 6.42%
On the development of the vaccine.

Oxford University also announced on Saturday that it would begin a trial for the coronovirus candidate, which is developing alongside AstraZeneca Ezanne,
-0.33%.
The study was stopped after a UK patient fell ill last week. Oxford University said it was considered safe to continue. AstraZeneca shares rose 0.5%.

US-based Gilead Sciences Inc. GILD on Sunday announced a $ 21 billion deal to buy biotech Immunomedics Inc. IMMU, a leading breast cancer drug maker.

Japanese technology conglomerate Softbank Group Corp announced a $ 40 billion deal late Sunday to sell UK-based microprocessor designer Arm Holdings to chipmaker Nvidia NVDA.
-1.19%
For a mixture of cash and stock.

The technology sector was also lifted by M&A with shares of the German software group SAP SE SAP,
+ 0.01%
0.3% and chip equipment manufacturer ASML Holding NV ASML,
+ 0.62%

ASML,
+ 0.35%
Up to 0.3%.

And the race for TikTok is heating up. Software Group Oracle Corp ORCL,
-0.57%
The video-sharing app was tipped to take over the US after China’s Bytdans explicitly rejected an offer from technology giant Microsoft Corp MSFT.
-0.65%
But in the latest twist, Chinese state media say ByteDance has also turned down Oracle.

Elsewhere, Euronext NV ENX,
-3.09%
Monday said it has submitted a non-binding offer to acquire Borsa Italia from London Stock Exchange Group plc LSE.
-1.30%.
Pan-European Exchange partnered with Italian lenders Kaspa Depositi e Presti Equity and Intesa Sanpolo Spa ISP,
-0.25%
On offer. Euronext shares fell 0.2% and London Stock Exchange shares fell 0.5%.

    .